Personalized cell therapy aims to free transplant patients from lifelong drugs
Disease control
Ongoing
This study is testing a new, personalized cell therapy called QEL-001. It is made from a patient's own immune cells, which are modified in a lab to help the body accept a donated liver. The goal is to see if this therapy is safe and if it can allow patients to safely stop taking …
Phase: PHASE1, PHASE2 • Sponsor: Quell Therapeutics Limited • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC